Level of Exercise Influences the Severity of Fatigue, Energy Levels, and Sleep Disturbance in Oncology Outpatients Receiving Chemotherapy
- PMID: 32897907
- DOI: 10.1097/NCC.0000000000000875
Level of Exercise Influences the Severity of Fatigue, Energy Levels, and Sleep Disturbance in Oncology Outpatients Receiving Chemotherapy
Abstract
Background: Fatigue and sleep disturbance are common co-occurring symptoms in patients receiving chemotherapy. While the results from meta-analyses support the use of exercise to decrease the severity of these symptoms, information is needed on patients' "real world experiences" with the use of exercise.
Objective: The aims of this study were to determine distribution of patients who did and did not exercise on a regular basis and evaluate for differences in demographic and clinical characteristics, as well as the severity of fatigue, decrements in energy, and sleep disturbance among the exercise groups.
Methods: Patients (n = 1033) completed self-report questionnaires prior to their second or third cycle of chemotherapy. Patients were categorized into 3 exercise (Ex) groups (ie, NoEx, <150 min/wk [LessEx]; ≥150 min/wk [RecEx]). Differences among the groups were evaluated using parametric and nonparametric tests.
Results: Only 19.1% of the patients were in the RecEx group. Patients in the NoEx group (37.2%) had fewer years of education, were more likely to be non-White and unemployed, had a higher body mass index, and a worse comorbidity profile. Patients in the NoEx group had higher levels of morning fatigue, lower levels of morning and evening energy, and higher levels of sleep disturbance.
Conclusions: Findings from this real-world study suggest that lack of physical activity is associated with higher levels of fatigue and sleep disturbance.
Implications for practice: Given that the most frequently used intervention in this study was walking, clinicians can recommend this inexpensive intervention to patients to manage fatigue and sleep disturbance.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Similar articles
-
Age differences in fatigue, decrements in energy, and sleep disturbance in oncology patients receiving chemotherapy.Eur J Oncol Nurs. 2016 Aug;23:115-23. doi: 10.1016/j.ejon.2016.07.002. Epub 2016 Jul 15. Eur J Oncol Nurs. 2016. PMID: 27456383 Free PMC article.
-
Common and Distinct Characteristics Associated With Trajectories of Morning and Evening Energy in Oncology Patients Receiving Chemotherapy.J Pain Symptom Manage. 2017 May;53(5):887-900.e2. doi: 10.1016/j.jpainsymman.2016.12.339. Epub 2017 Jan 4. J Pain Symptom Manage. 2017. PMID: 28063861 Free PMC article.
-
Impact of worst pain severity and morning fatigue profiles on oncology outpatients' symptom burden and quality of life.Support Care Cancer. 2022 Dec;30(12):9929-9944. doi: 10.1007/s00520-022-07431-6. Epub 2022 Nov 10. Support Care Cancer. 2022. PMID: 36355215
-
Morning Fatigue Severity Profiles in Oncology Outpatients Receiving Chemotherapy.Cancer Nurs. 2019 Sep/Oct;42(5):355-364. doi: 10.1097/NCC.0000000000000626. Cancer Nurs. 2019. PMID: 30024437 Free PMC article.
-
Multidimensional Model of Energy in Patients With Cancer.Semin Oncol Nurs. 2024 Jun;40(3):151644. doi: 10.1016/j.soncn.2024.151644. Epub 2024 Apr 30. Semin Oncol Nurs. 2024. PMID: 38692969 Review.
Cited by
-
Uncovering Methods and Outcomes of Palliative Care for Geriatric Patients: A Scoping Review.J Multidiscip Healthc. 2023 Sep 27;16:2905-2920. doi: 10.2147/JMDH.S429323. eCollection 2023. J Multidiscip Healthc. 2023. PMID: 37790991 Free PMC article.
-
Self-Completion Questionnaire on Sleep Evaluation in Patients Undergoing Oxaliplatin Therapy: An Observational Study.Cancers (Basel). 2024 Feb 26;16(5):946. doi: 10.3390/cancers16050946. Cancers (Basel). 2024. PMID: 38473307 Free PMC article.
-
Visual analysis of the research frontiers, hotspots and trends of exercise therapy intervention in tumor-related sleep-wake disorders.Front Oncol. 2024 Apr 29;14:1392844. doi: 10.3389/fonc.2024.1392844. eCollection 2024. Front Oncol. 2024. PMID: 38741781 Free PMC article.
References
-
- American Cancer Society. Cancer Treatment & Survivorship—Facts & Figures 2019–2021. Atlanta, GA: American Cancer Society; 2019.
-
- Pearce A, Haas M, Viney R, et al. Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study. PLoS One. 2017;12(10):e0184360.
-
- Berger AM, Mooney K, Banerjee A, et al. NCCN guidelines version 1.2020—cancer-related fatigue. National Comprehensive Cancer Network, Inc. https://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf. Accessed February 21, 2020.
-
- Thong MSY, van Noorden CJF, Steindorf K, Arndt V. Cancer-related fatigue: causes and current treatment options. Curr Treat Options Oncol. 2020;21(2):17.
-
- Palesh O, Peppone L, Innominato PF, et al. Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancer. Nat Sci Sleep. 2012;4:151–162.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical